JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiore, A. C.
Right arrow Articles by King, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiore, A. C.
Right arrow Articles by King, H.

The Journal of Thoracic and Cardiovascular Surgery, Vol 84, 560-568, Copyright © 1982 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Prosthetic replacement for the thoracic vena cava: an experimental study

AC Fiore, JW Brown, RS Cromartie, LC Ofstein, PS Peigh, NS Sears, WP Deschner and H King

The superior vena cava (SVC) and thoracic inferior vena cava (IVC) were replaced in 46 dogs with autologous vein, knitted Dacron, glutaraldehyde-fixed porcine pericardium, unsupported polytetrafluorethylene (PTFE), and externally stented PTFE. After 30 days, patency rates were determined by contrast venography and were 100%, 9%, 50%, 75%, and 100%, respectively. The patency rates of Dacron and glutaraldehyde-fixed pericardium are considered unacceptable when compared to autologous vein (p less than 0.05). Stented PTFE exhibited a patency rate equal to that of autologous vein at 30 days, minimal graft reaction, excellent incorporation by host fibroblasts, and a smooth neointima. The external spiral support added to PTFE enchanced the thromboresistance of this graft in the thoracic venous system. Long- term follow-up is required to determine if the stented PTFE prosthesis remains comparable to autologous vein as a venous conduit.


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
W. Wells, M. Malas, C. J. Baker, S. M. Quardt, and M. L. Barr
Depopulated vena caval homograft: a new venous conduit
J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 498 - 503.
[Abstract] [Full Text] [PDF]

Home page
 VASC ENDOVASCULAR SURGHome page
P. Sapienza, J. D. Edwards, P. E. Mcgregor, and P. E. Thorpe
Dacron Graft Replacement with Bilateral Renal Vein Reimplantation for Inferior Vena Cava Leiomyosarcoma: A Case Report
Vascular and Endovascular Surgery, March 1, 1996; 30(2): 163 - 168.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. A. Gonzalez-Fajardo, M. Garcia-Yuste, S. Florez, G. Ramos, T. Alvarez, and J. M. Coca
Hemodynamic and cerebral repercussions arising from surgical interruption of the superior vena cavaExperimental model
J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1044 - 1049.
[Abstract] [Full Text]

Home page
 VASC ENDOVASCULAR SURGHome page
G. Motta, G.B. Ratto, A. Sacco, T. Ogata, H. Masuda, K. Kikuchi, K. Takagi, S. Tanaka, H. Yoshizu, and A. Senoo
Healing and Long-Term Viability of Grafts in the Venae Cavae Reconstruction
Vascular and Endovascular Surgery, September 1, 1987; 21(5): 316 - 330.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1982 by The American Association for Thoracic Surgery.